Attention-Deficit/Hyperactivity Disorder in Adults

Primary Psychiatry

Volumn 10, Issue 4, 2003, Pages 77-80

  Pierce, Karen ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABDOMINAL PAIN; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; COMORBIDITY; DISEASE SEVERITY; DISTRACTIBILITY; HEADACHE; HUMAN; IMPULSIVENESS; LIFESPAN; PREVALENCE; REVIEW; SIDE EFFECT;

EID: 0346673855     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Goldman L, Genel M. Diagnosis and treatment of attention deficit/hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100-1107.
2. Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000;48:9-20.
3. Diagnostic and Statistical Manual of Mental Disorders. 4th ed text-revision. Washington, DC: American Psychiatric Association; 2000:85-93.
4. Biederman J. Attention-deficit/hyperactivity disorder: a lifespan perspective. J Clin Psychiatry. 1998;59(suppl 7):4-16.
5. Schweitzer JB, et al, Attention-deficit hyperactivity disorder. Med Clin North Am 2001;85:757-777.
6. Murphy K, Barkley RA. Attention deficit hyperactivity disorder in adults: comorbidites and adaptive impairments. Compr Psychiatry. 1996;37:393-401.
7. Heilegenstein E, Keeling RP. Presentation of unrecognized attention deficit hyperactivity disorder in college students. J Am Coll Health. 1995;43:226-228.
8. Biederman J, Faraone S, Milberger S, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35:343-351.
9. Biederman J, Faraone SV, Mick E, et al. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry. 1999;38:966-975.
10. Pomerleau OF, Downey KK, Stelson FW, et al. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subs Abuse. 1995;7:373-378.
11. Simkin DR. Adolescent substance use disorders and comorbidity. Pediatr Clin North Am. 2000;49:463-477.
12. Barkley RA, Murphy KR, DePaul GR, et al. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functions. J Int Neuropsychol Soc. 2002;8:655-672.
13. Hudziak JJ, Heath AC, Madden PF. Latent class factor analysis of DSM-IV ADHD: A twin study of female adolescents. J Am Acad Child Adolesc Psychiatry, 1998;34:848-857.
14. Faraone SV, Biederman J, Mick E. Symptom reports by adults with attention deficit hyperactivity disorder: are they influenced by attention deficit hyperactivity disorder in their children? J Nerv Ment Dis. 1997;185:583-584.
15. Casey BJ, et al. Implication of right fronto-striatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36:374-383.
16. Multi-Health Systems. Conners' Adult Attention Deficit Rating Scale (CAARS). North Tonawanda, NY: Multi-health Systems Inc.; 1994:138.
17. Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002(suppl 2):26S-48S.
18. The ADDA Guiding Principles for Coaching Individuals With Attention Deficit Disorders. Available at: http://www.add.org/content/coach/ coachingguidlines2.htm. Accessed: March 2003.
19. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficity disorder in adults. Arch Gen Psychiatry. 1984;41:1059-1063.
20. Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985;142:547-552.
21. Gualtieri CT, Ondrusek MG, Finley C. Attention deficit disorders in adults. Clin Neuropharmacol. 1985;8:343-356.
22. Shekim WO, Antun F, Hanna GL, McCracken JT, Hess EB. S-adenosyl-L-methionine (SAM) in adults with ADHD, RS: preliminary results from an open trial. Psychopharmacol Bull. 1990;26:249-253.
23. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit disorder. Arch Gen Psychiatry. 1995;52:434-443.
24. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153:1147-1153.
25. Wilens TE, Biederman J, Spencer TJ, et al. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 1999;19:257-264.
26. Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 1999;33:494-502.
27. Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000;10:311-320.
28. Horrigan JP, Barnhill LI. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2000;61:414-417.
29. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58:775-782.
30. Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2001;21:223-228.
31. Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108:E83.
32. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53:112-120.
33. Weiss G, Hechtman L, Milroy T, et al. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry. 1985;24:211-220.